(Q47561348)

4 February 2018

title

ATM missense mutations are frequent in patients with breast cancer (English)

1 reference

4 February 2018

author

Jeff Longmate

6

1 reference

4 February 2018

author name string

Steve S Sommer

1

1 reference

4 February 2018

Zefei Jiang

2

1 reference

4 February 2018

Jinong Feng

3

1 reference

4 February 2018

Carolyn H Buzin

4

1 reference

4 February 2018

Jian Zheng

5

1 reference

4 February 2018

Mira Jung

7

1 reference

4 February 2018

Jefferson Moulds

8

1 reference

4 February 2018

Anatoly Dritschilo

9

1 reference

4 February 2018

publication date

1 September 2003

1 reference

4 February 2018

Cancer Genetics and Cytogenetics

published in

1 reference

4 February 2018

volume

145

1 reference

4 February 2018

issue

2

1 reference

4 February 2018

page(s)

115-120

1 reference

4 February 2018

Recent trends in breast cancer incidence and mortality

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900119-5

7 January 2021

Breast cancer genetics: what we know and what we need

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900119-5

7 January 2021

A single ataxia telangiectasia gene with a product similar to PI-3 kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900119-5

7 January 2021

Incidence of cancer in 161 families affected by ataxia-telangiectasia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900119-5

7 January 2021

Cancer risks in A-T heterozygotes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900119-5

7 January 2021

ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900119-5

7 January 2021

Diversity ofATM gene mutations detected in patients with ataxia-telangiectasia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900119-5

7 January 2021

Heterozygous ATM mutations do not contribute to early onset of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900119-5

7 January 2021

Dominant Negative ATM Mutations in Breast Cancer Families

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900119-5

7 January 2021

Elevated frequency of ATM gene missense mutations in breast cancer relative to ethnically matched controls

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900119-5

7 January 2021

Missense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900119-5

7 January 2021

Scanning by DOVAM-S detects all unique sequence changes in blinded analyses: evidence that the scanning conditions are generic

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900119-5

7 January 2021

Detection of virtually all mutations-SSCP (DOVAM-S): a rapid method for mutation scanning with virtually 100% sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900119-5

7 January 2021

Methods of adjustment for estimating the attributable risk in case-control studies: A review

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900119-5

7 January 2021

The estimation and interpretation of attributable risk in health research

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900119-5

7 January 2021

Mutations at the ataxia-telangiectasia locus and clinical phenotypes of A-T patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900119-5

7 January 2021

Are rare variants responsible for susceptibility to complex diseases?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900119-5

7 January 2021

Increased frequency of ATM mutations in breast carcinoma patients with early onset disease and positive family history

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900119-5

7 January 2021

Cancer risk and the ATM gene: a continuing debate

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900119-5

7 January 2021

Cancer risk in ATM heterozygotes: a model of phenotypic and mechanistic differences between missense and truncating mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900119-5

7 January 2021

Ovarian cancer: loss of heterozygosity frequently occurs in the ATM gene, but structural alterations do not occur in this gene

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900119-5

7 January 2021

Absence of somatic ATM missense mutations in 58 mammary carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900119-5

7 January 2021

Mice heterozygous for mutation in Atm, the gene involved in ataxia-telangiectasia, have heightened susceptibility to cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900119-5

7 January 2021

Constitutional alterations of the ATM gene in early onset sporadic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2803%2900119-5

7 January 2021

10.1016/S0165-4608(03)00119-5

Identifiers

DOI

1 reference

4 February 2018

PubMed ID

12935922

1 reference

4 February 2018